PRTN3 and rheumatoid arthritis: However, this suggests the possibility that Gal1 could be a possible diagnostic biomarker to differentiate between SpA and RA patients when the patients are at early stages of the disease, especially in those patients HLA-B27, RF and ACPA negative.